ArticleNature communications2026
Integrated device for optoacoustically-guided ultrasound surgery.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
High-intensity focused ultrasound has emerged as a promising tool for treating tumors and other pathologies by inducing localized thermal lesions. However, treatment outcomes depend strongly on accurate coverage of the treated region and monitoring lesion formation in real time. While magnetic resonance imaging has successfully been used to guide high-intensity focused ultrasound therapy, it significantly increases the cost and complexity of the treatment. To address these limitations, we have developed a system that integrates real-time three-dimensional tomographic optoacoustic imaging with concurrent focused ultrasound emission using a high-frequency spherical array transducer. We evaluated the performance of the system in the mouse brain ex vivo and further assessed its clinical translatability in a living sheep, demonstrating successful induction of a confined thermal lesion beneath the cortical surface, as confirmed by magnetic resonance imaging and histology. The system enabled precise treatment targeting, while optoacoustic signal changes during sonication provided a reliable indicator of thermal lesion progression. This capability allowed on-the-fly adjustment of the thermal dose, helping to minimize the risk of vascular damage or adverse effects on off-target structures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.